Document is current
Any future updates will be listed below
-
Authors
Goldsbury, David E. https://orcid.org/0000-0001-6247-2706
Kang, Yoon-Jung https://orcid.org/0000-0003-4045-1941
Tang, Catherine https://orcid.org/0000-0002-0223-8341
Tanha, Hamzeh M. https://orcid.org/0000-0003-0818-3481
Smit, Amelia K. https://orcid.org/0000-0001-5712-220X
Dunlop, Kate L. A. https://orcid.org/0000-0001-9544-9764
Petelin, Lara https://orcid.org/0000-0003-3245-8895
Ngo, Preston https://orcid.org/0000-0001-5453-0734
Hui, Harriet https://orcid.org/0009-0006-4548-1217
Meagher, Nicola S. https://orcid.org/0000-0001-9134-2118
Merritt, Melissa A. https://orcid.org/0000-0002-5067-6119
Weber, Marianne https://orcid.org/0000-0001-5731-9651
DeFazio, Anna https://orcid.org/0000-0003-0057-4744
Cust, Anne E. https://orcid.org/0000-0002-5331-6370
Canfell, Karen https://orcid.org/0000-0002-6443-6618
Steinberg, Julia https://orcid.org/0000-0002-0585-2312
-
Funding
Funding for this research was provided by:
Cancer Institute NSW (2022/CDF1154)
Department of Health | National Health and Medical Research Council (MRFF 1200535, MRF2007708, 2008454, MRFF2024995, MRFF 1200535, 2009923, 2024995, APP1194679)
U.S. Department of Defense (W81XWH-21-1-0914)
- License Information
-
More Information
Article History
Received: 27 June 2024
Revised: 5 February 2025
Accepted: 11 February 2025
First Online: 27 February 2025
Competing interests
: Professor Karen Canfell is co-principal investigator of an investigator-initiated trial of cervical screening, Compass, run by the Australian Centre for Prevention of Cervical Cancer (ACPCC), which is a government-funded not-for-profit charity; the ACPCC has received equipment and a funding contribution from Roche Molecular Diagnostics, and operational support from the Australian Government. KC is also co- principal investigator on a major investigator-initiated implementation programme Elimination Partnership in Cervical Cancer (EPICC) which receives support from the Australian government and Minderoo Foundation and equipment donations from Cepheid. Anna DeFazio has received research support from AstraZeneca and Illumina. David E Goldsbury, Yoon-Jung Kang, Catherine Tang, Hamzeh M Tanha, Amelia K Smit, Kate L A Dunlop, Lara Petelin, Preston Ngo, Harriet Hui, Nicola S Meagher, Melissa A Merritt, Marianne Weber, Anne E Cust and Julia Steinberg declare that they have no conflict of interest.
: The conduct of the Sax Institute’s 45 and Up Study was approved by the University of New South Wales Human Research Ethics Committee. The NSW Population Health and Health Services Research Ethics Committee approved the work described here (HREC/14/CIPHS/54).
